Joaquín Arribas Selected Research

protransforming growth factor alpha

11/2005

Recycling of cell surface pro-transforming growth factor-{alpha} regulates epidermal growth factor receptor activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joaquín Arribas Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 03/2003
27	Breast Neoplasms (Breast Cancer) 05/2022 - 03/2007
10	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2004
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021 - 01/2018
3	Carcinogenesis 12/2018 - 03/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Cachexia 12/2021
1	Muscular Atrophy (Muscle Atrophy) 12/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Myocarditis (Carditis) 01/2021
1	Disease Progression 01/2021
1	Pathologic Complete Response 01/2019
1	Inflammation (Inflammations) 01/2018
1	Fibrosis (Cirrhosis) 04/2015
1	Adenocarcinoma 04/2015
1	Circulating Neoplastic Cells 11/2013
1	Carcinoma (Carcinomatosis) 11/2013
1	Li-Fraumeni Syndrome 11/2013

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2016
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 07/2006
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
6	Metalloproteases (Metalloproteinases)IBA 01/2010 - 05/2005
5	Phosphotransferases (Kinase)IBA 11/2021 - 08/2004
5	Trastuzumab (Herceptin)FDA Link 01/2019 - 11/2014
4	human ERBB2 proteinIBA 03/2020 - 11/2010
4	Pharmaceutical PreparationsIBA 10/2019 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2004
3	CytokinesIBA 01/2021 - 05/2015
3	Imatinib Mesylate (Gleevec)FDA Link 02/2020 - 01/2018
3	AntibodiesIBA 12/2018 - 07/2006
3	ErbB Receptors (EGF Receptor)IBA 03/2007 - 10/2004
3	Peptide Hydrolases (Proteases)FDA Link 07/2005 - 12/2002
2	eribulin FDA Link 05/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 06/2013
2	Bispecific AntibodiesIBA 01/2021 - 10/2018
2	Immunoconjugates (Immunoconjugate)IBA 03/2020 - 01/2017
2	Ado-Trastuzumab EmtansineIBA 03/2020 - 01/2017
2	Estrogen ReceptorsIBA 01/2020 - 11/2010
2	Phenobarbital (Luminal)FDA Link 01/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 10/2016 - 05/2015
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 03/2003
2	Complementary DNA (cDNA)IBA 10/2004 - 08/2004
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	InterferonsIBA 01/2022
1	PlatinumIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	AnthracyclinesIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	taxaneIBA 01/2021
1	trastuzumab duocarmazineIBA 03/2020
1	capivasertibIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	copanlisibIBA 01/2020
1	Cyclin DIBA 01/2019
1	Taxoids (Taxanes)IBA 01/2019
1	Ligases (Synthetase)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2018
1	ProteomeIBA 12/2018
1	PM 01183IBA 11/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2018
1	AntigensIBA 10/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Caspase 8 (Caspase-8)IBA 11/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2016
1	Blocking AntibodiesIBA 10/2016
1	Drug CombinationsIBA 01/2016
1	LigandsIBA 01/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2015
1	ibrutinibIBA 04/2015
1	Lapatinib (GW572016)FDA Link 11/2013
1	Biological ProductsIBA 03/2011
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2010
1	Estrogens (Estrogen)FDA Link 11/2010
1	Semaphorins (Semaphorin)IBA 01/2010
1	CortactinIBA 09/2009
1	DisulfidesIBA 09/2009
1	AngiopoietinsIBA 06/2009
1	IntegrinsIBA 06/2009

Therapy/Procedure

18	Therapeutics 01/2022 - 03/2003
4	Drug Therapy (Chemotherapy) 01/2019 - 11/2014
2	Immunotherapy 01/2022 - 01/2021
1	Radiotherapy 01/2020
1	Aftercare (After-Treatment) 10/2019
1	Neoadjuvant Therapy 01/2019
1	Precision Medicine 01/2017